S. P. Beebe

1.6k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

S. P. Beebe is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, S. P. Beebe has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 1 paper in Infectious Diseases. Recurrent topics in S. P. Beebe's work include Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (6 papers). S. P. Beebe is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (6 papers). S. P. Beebe collaborates with scholars based in United States, Taiwan and Canada. S. P. Beebe's co-authors include Yun‐Fan Liaw, Uchenna H. Iloeje, Samuel S. Lee, Eugene R. Schiff, Hui Zhang, Ching‐Lung Lai, Rifaat Safadi, R. Hindes, Zachary Goodman and Ting‐Tsung Chang and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Gastroenterology and Hepatology.

In The Last Decade

S. P. Beebe

8 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡

2010 735 citations Ting‐Tsung Chang, Yun‐Fan Liaw et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. P. Beebe United States	4	1.1k	1.0k	39	33	21	9	1.1k
Halil Değertekin Türkiye	16	917 0.9×	866 0.9×	44 1.1×	31 0.9×	4 0.2×	47	981
Anne Varaut France	8	383 0.4×	356 0.4×	51 1.3×	24 0.7×	13 0.6×	10	446
S. Lobello Italy	8	579 0.6×	572 0.6×	20 0.5×	26 0.8×	4 0.2×	16	630
Simon Siu‐Man Sum China	13	584 0.6×	534 0.5×	65 1.7×	22 0.7×	11 0.5×	22	647
María Sales Gilabert Spain	2	476 0.5×	534 0.5×	189 4.8×	18 0.5×	11 0.5×	5	624
Corinne Njapoum France	5	404 0.4×	366 0.4×	14 0.4×	15 0.5×	12 0.6×	6	471
Nami Mori Japan	12	324 0.3×	319 0.3×	64 1.6×	41 1.2×	27 1.3×	31	449
Chandana Pande India	10	674 0.6×	622 0.6×	49 1.3×	63 1.9×	29 1.4×	14	758
Waleed Al–Hamoudi Saudi Arabia	14	362 0.3×	322 0.3×	21 0.5×	26 0.8×	7 0.3×	29	424
Gianfranca Stornaiuolo Italy	12	619 0.6×	564 0.6×	39 1.0×	29 0.9×	6 0.3×	23	695

Countries citing papers authored by S. P. Beebe

Since Specialization

Citations

This map shows the geographic impact of S. P. Beebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. P. Beebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. P. Beebe more than expected).

Fields of papers citing papers by S. P. Beebe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. P. Beebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. P. Beebe. The network helps show where S. P. Beebe may publish in the future.

Co-authorship network of co-authors of S. P. Beebe

This figure shows the co-authorship network connecting the top 25 collaborators of S. P. Beebe. A scholar is included among the top collaborators of S. P. Beebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. P. Beebe. S. P. Beebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Manns, Michael P., Ulus Salih Akarca, Ting‐Tsung Chang, et al.. (2012). Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901. Expert Opinion on Drug Safety. 11(3). 361–368. 38 indexed citations

2.

Liaw, Yun‐Fan, M. Raptopoulou‐Gigi, Hugo Cheinquer, et al.. (2011). Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study. Hepatology. 54(1). 91–100. 163 indexed citations

3.

Schiff, Eugene R., Samuel S. Lee, Seung Kew Yoon, et al.. (2011). BRIEF COMMUNICATION Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B. 1 indexed citations

4.

Schiff, Eugene R., Samuel S. Lee, You‐Chen Chao, et al.. (2010). Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology. 9(3). 274–276.e1. 137 indexed citations

5.

Chang, Ting‐Tsung, Yun‐Fan Liaw, Eugene R. Schiff, et al.. (2010). Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡. Hepatology. 52(3). 886–893. 735 indexed citations breakdown →

6.

Min, Albert D., Naoky Tsai, Michael P. Manns, et al.. (2010). M1901 Low Rates of Nucleos(T)Ide-Associated Adverse Events in the Long-Term Experience With Entecavir. Gastroenterology. 138(5). S–832.

7.

Tong, Myron J., Ting‐Tsung Chang, Shun‐Sheng Wu, et al.. (2010). 633 Histologic Improvement in Asian Patients With HBeAg(+) and HBeAg(−) Chronic Hepatitis B After Long-Term Treatment With Entecavir: Results From ETV-022, -027 and -901 Studies. Gastroenterology. 138(5). S–793. 1 indexed citations

8.

Schiff, Eugene R., Samuel S. Lee, You‐Chen Chao, et al.. (2009). W1808 Regression of Fibrosis/Cirrhosis with Long-Term Entecavir Therapy in Chronic Hepatitis B (CHB) Patients with Baseline Bridging Fibrosis or Cirrhosis: Results from Studies ETV-022, -027 and -901. Gastroenterology. 136(5). A–866. 1 indexed citations

9.

Liaw, Yun‐Fan, Ting‐Tsung Chang, Shun‐Sheng Wu, et al.. (2009). 320 Long-Term Histologic Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs. Gastroenterology. 136(5). A–798. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact